News Focus
News Focus
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: corporalagarn post# 317738

Friday, 11/10/2017 11:59:26 AM

Friday, November 10, 2017 11:59:26 AM

Post# of 347009
coporal, I think most have been paying attention and are aware that RONIN can sell of PS-targeting R&D for breadcrumbs and quick self profit on top of the profitable PPHM position RONIN already has. Only a shareholder since Q1/2017 for the bulk of their 5+% position.


Have you been paying attention? No matter who "wins" the science is being sold or licensed off.



Every 45Mil$ gives RONIN 1$ extra profit. Every Month DELAY reduces RONIN's yearly % profit rate as their money is LOCKED in PPHM. Activists as RONIN do not like that.

So rather a MIXED BoD where the 3 RONIN guys push for the SELL/LICENSING of PS-targeting and WHERE the 4 PPHM guys make sure the deal is DONE at the MAXIMAL REASONABLE price in SHAREHOLDERS INTEREST.

Actually the above was another ADVANTAGE of a MIX BoD formed by CEO King + 3 NEW PPHM and 3 NEW RONIN.

I am discovering new advantages of UNBALANCING the PPHM WHITE CARD VOTE by voting candidates in and withholding DP, ES and CJ.


AIMO

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y